SEC Form 4 · accession 0001252491-15-000002
TENAX THERAPEUTICS, INC. · TENX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Ronald R Blanck
Director
Period of report
Nov 19, 2015
Accepted (ET)
Nov 19, 2015 · 1:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000034956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common stock | Nov 19, 2015 | P | 1,900 | $3.20 | A | 14,799 | D |
Table II — derivative securities
No Table II lines on this filing.